KUAISHOU-W
01024
XIAOMI-W
01810
JD HEALTH
06618
4
BILIBILI-W
09626
5
ALI HEALTH
00241
HK Stock MarketDetailed Quotes
06855 ASCENTAGE-B
- 37.200
- +1.300+3.62%
Market Closed Feb 18 16:08 CST
12.96BMarket Cap-32.83P/E (TTM)
37.450High35.650Low4.37MVolume35.950Open35.900Pre Close160.69MTurnover1.25%Turnover RatioLossP/E (Static)348.27MShares48.85052wk High15.43P/B12.96BFloat Cap15.42052wk Low--Dividend TTM348.27MShs Float58.200Historical High--Dividend LFY5.01%Amplitude11.160Historical Low36.800Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
About ASCENTAGE-B Company
Aspartic Pharma is a globally focused clinical-stage biotechnology company dedicated to developing novel therapies for cancer, hepatitis B virus, and age-related diseases. The company focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. Aspiration Pharma has developed new products including eight drug candidates, including novel high-potency Bcl-2/Bcl-XL inhibitors, drug candidates targeting IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. The company has conducted 28 phase I/II clinical trials to evaluate eight products in the US, Australia, and China to develop potential therapies as single drugs or combinations.
Company Profile
Symbol06855
Company NameASCENTAGE-B
ISINKYG0519B1023
Listing DateOct 28, 2019
Issue Price34.20
Shares Offered12.18M share(s)
FoundedNov 17, 2017
Registered AddressCayman Islands
Chairmandajun yang
Secretaryzhangqi wang
Audit InstitutionErnst & Young
Company CategoryOther
Registered OfficeWalkers Corporate Limited Cayman Corporate Centre 27 Hospital Road George Town Grand Cayman KY1-9008 Cayman Islands
Head Office and Principal Place of BusinessFlat B, 17th Floor, United Centre, 95 Queensway, Admiralty, Hong Kong
Fiscal Year Ends12-31
Employees574
MarketHong Kong motherboard
Phone(86)51285557777
EmailIR@ascentage.com
Websitehttp://www.ascentage.cn
Business Yasheng Pharmaceutical Group is a holding company mainly engaged in the discovery, development and commercialization of drugs for hematologic malignancies. The company's main business is to develop and sell novel small-scale therapies for cancer, hepatitis B virus, and certain age-related diseases. The company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), and APG-5918. The company's products are mainly used to treat major hematological malignancies, including chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and multiple myeloma. The company mainly operates in the domestic market.
Company Executives
- Name
- Position
- Salary
- dajun yang
- Chairman of the Board, CEOs, Executive Director, Authorized Representative
- --
- shaomeng wang
- Non-executive Directors, Chairman of the Scientific Advisory Board
- --
- dazhong lv
- Non-executive Directors, Audit Committee Members
- --
- zhangqing ye
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members
- --
- wei ren
- Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members
- --
- David Sidransky
- Independent Non-Executive Director, Chairman of the Nomination Committee
- --
- Marina S. Bozilenko
- Independent Non-Executive Director, Audit Committee Members
- --
- Debra Yu
- Independent Non-Executive Director, Remuneration Committee Members
- --
- Marc E. Lippman, MD
- Independent Non-Executive Director, Nomination Committee Members
- --
- yifan di
- Chief Medical Officer
- --
- Raymond Jeffrey KMETZ
- Chief Commercial Officer
- --
- Thomas Joseph KNAPP
- Senior Vice President, General Counsel
- --
- zhangqi wang
- Authorized Representative, Company Secretary
- --
- gang zhu
- Chief Commercial Operations Officer
- --
Trending Stocks
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data.
Unlock Now